| # | Drug | Count |
|---|---|---|
| 0 | BUDESONIDE | 6 |
| 1 | VENLAFAXINE | 6 |
| 2 | VENLAFAXINE HYDROCHLORIDE | 6 |
| 3 | AZATHIOPRINE | 5 |
| 4 | ESKETAMINE HYDROCHLORIDE | 5 |
| 5 | LACTULOSE | 5 |
| 6 | LAMOTRIGINE | 5 |
| 7 | RIFAXIMIN | 5 |
| 8 | URSODIOL | 5 |
| 9 | URSOSIOL | 5 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | COCAINE HYDROCHLORIDE NASAL | 1 | 0.0154 |
| 1 | ILOPROST | 1 | 0.0011 |
| 2 | MOGAMULIZUMAB-KPKC | 1 | 0.0007 |
| 3 | ESKETAMINE HYDROCHLORIDE | 5 | 0.0003 |
| 4 | URSOSIOL | 5 | 0.0003 |
| 5 | RIFAXIMIN | 5 | 0.0002 |
| 6 | URSODIOL | 5 | 0.0002 |
| 7 | LACTULOSE | 5 | 0.0001 |
| 8 | ACALABRUTINIB | 1 | 0.0001 |
| 9 | AZATHIOPRINE | 5 | 0.0001 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 10 |
| 1 | Anti-epileptic Agent [EPC] | 5 |
| 2 | Bile Acid [EPC] | 5 |
| 3 | Mood Stabilizer [EPC] | 5 |
| 4 | Osmotic Laxative [EPC] | 5 |
| 5 | Purine Antimetabolite [EPC] | 5 |
| 6 | Rifamycin Antibacterial [EPC] | 5 |
| 7 | CD38-directed Cytolytic Antibody [EPC] | 3 |
| 8 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 3 |
| 9 | Thalidomide Analog [EPC] | 3 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Prostacycline [EPC] | 1 | 0.0011 |
| 1 | Chemokine Receptor Type 4 Interaction [EPC] | 1 | 0.0007 |
| 2 | CD38-directed Cytolytic Antibody [EPC] | 3 | 0.0005 |
| 3 | Bile Acid [EPC] | 5 | 0.0002 |
| 4 | Rifamycin Antibacterial [EPC] | 5 | 0.0001 |
| 5 | Purine Antimetabolite [EPC] | 5 | 0.0001 |
| 6 | B Lymphocyte Stimulator-specific Inhibitor [EPC] | 1 | 0.0000 |
| 7 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 3 | 0.0000 |
| 8 | Mood Stabilizer [EPC] | 5 | 0.0000 |
| 9 | Anti-epileptic Agent [EPC] | 5 | 0.0000 |